ORIGINAL ARTICLE, Josh Scott, betakit.com, October 20, 2022 Backed by decades of research, VoxNeuro aims to bring objectivity to brain health assessments. Cognitive health assessments
Applications are now open for this year’s cohort of innovative startups Hamilton – October 12, 2022 – Fresh off the heels of celebrating innovation at
Making a smart site selection could drive the commercialization of your intellectual property. Here are three examples that are helping to make Hamilton, Ontario, the next leader in life sciences research and commercialization.
The partnership between Koble and Maple will provide much-needed support for an underserved group – new and expecting parents.
ORIGINAL PRESS RELEASE, PR Newswire, September 21, 2022 Adapsyn Bioscience Inc., a chemical bioinformatics company that discovers novel drug-like small molecules, today announced a strategic
Eye3 has gained significant traction including securing financing, developing product concepts and prototypes and filing for patents.
$50,000 Awarded as 300 Members of the Innovation Community Celebrate HAMILTON, ON – September 29, 2022 – Boardball Inc. was named the grand prize winner
Original Press Release, Yahoo Finance, September 21, 2022 NORTH BRUNSWICK, N.J., Sept. 21, 2022 — Lactiga Therapeutics, an early-stage biotechnology company focused on improving the
Take a listen to our latest podcast as Rachel Bartholomew, CEO and Founder of Hyivy Health shares her medical device commercialization journey.
Hamilton, Ontario, a long-standing leader in health and life science research and innovation, was recently recognized with a 2021 investment of $6 million from the
Swati Matta, CEO & Founder of Koble, shares her startup journey and POV on the challenges of being a woman in the tech industry.
Understanding the common commercialization hurdles mentioned above is one thing, but having the funding and the time to navigate through them is another.
Learn how Moonrise Medical is leveraging the CAMEDA program to scale its AI vascular imaging platform and accelerate its path to market.
Esphera SynBio, a synthetic biology platform is reprogramming the human body’s own communication system to deliver new cancer and infectious disease therapeutics, a solution with the power to impact many lives.
Kapoose Creek Bio is working with McMaster University for drug discovery and development to innovate treatments for neurological conditions.
Minister Tassi announces $5M Government of Canada investment into SOPHIE program renewal to support Canadian life sciences innovation.
Since 2021, Innovation Factory’s SOPHIE program has helped support the growth of over 160 innovative Ontario life science companies.
The Molecules and Masterpieces event showcased the SOPHIE program’s role as a catalyst for life science partnerships, commercialization and innovation.
Our website uses cookies to ensure you get the best experience. Learn more about the policy.
